If you have been refreshing the Federal Register waiting for the hemp rule, you are watching the wrong window.
Here is the exact query, so you can run it yourself. The Federal Register’s public API, searched for the term hemp cannabidiol and limited to documents published on or after August 1, 2026, answers with a count of 1. One document. One page of results.
That document is a USDA notice titled Submission for OMB Review; Comment Request, published August 13, 2026, at 91 FR 52276. It is a Paperwork Reduction Act filing — the agency telling the Office of Management and Budget it intends to keep collecting information from hemp producers. It is not a proposed rule, and it does not change what is legal to sell.
Its record carries no abstract and no formal comment-close date. The notice text asks for comments within 30 days of publication and says they are “best assured of having their full effect if received by September 14, 2026.” That is a paperwork burden estimate, not the thing consumers are worried about.
Scope that claim honestly
A term search is a term search. That count of 1 means one document matched hemp cannabidiol in the window we ran. It is not proof that nothing has been published under cannabis, delta-8, or tetrahydrocannabinol.
Where the language actually sits
The vehicle is an appropriations bill. The enrolled text of H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, is public on govinfo — “An Act Making continuing appropriations and extensions for fiscal year 2027, and for other purposes.” Inside it is a passage keyed to products described in paragraphs of section 297A of the Agricultural Marketing Act of 1946, 7 U.S.C. 1639o, as amended by section 781 of the same act. That citation is the hemp definition, and section 781 is the amendment doing the work.
We are not printing a threshold or a compliance date here. The figures circulating in headlines are real reporting, but we did not read them out of a primary document, and this site does not launder a snippet into a number.
For a buyer, the practical part is short. In the material we could open there is no proposed rule to track, and the only comment window in view is the one attached to that USDA paperwork notice. Keep the certificate of analysis for whatever you already own, because any per-container limit gets measured against total THC on the lab sheet, not against the front label — the same reason we kept coming back to the paperwork in Medicare’s $500 hemp allowance case.
Nothing here is a verdict on any product. CBD products are not FDA-approved, effects are what users report rather than what a bottle does, and a regulatory change is a reason to read your lab sheet, not to panic.